Tobacco and Disease:
Fourth Annual Lung Cancer Symposium
Check back for information about the next Lung Cancer Symposium.
The Tobacco and Disease: Fourth Annual Lung Cancer Symposium will provide up-to-date information on lung cancer to a target audience of physicians, respiratory and occupational therapists, nurses, pharmacists, other health care personnel, patients and advocates.
Statement of Need, Overall Purpose and Learner Objectives
Lung cancer is the leading cause of cancer death in the United States. This conference will cover the context within which lung cancer is caused. Where the tobacco culture’s political and social dimensions are relevant to the propagation of disease, the goals and methods of the tobacco industry will be discussed. After the breadth of tobacco-related disease has been explored, key principles and state-of-the-art thinking about lung cancer will be explored. The overall goal is to enable physicians, nurse practitioners, physician assistants, pharmacist, nurses and other health care professionals to be more effective at all levels of the fight against lung cancer. We hope to help prevent lung cancer and help improve the lives of those who have it.
At the conclusion of this activity, the participant will be able to:
- Discuss the global societal context of lung cancer
- Describe how the global context needs to be addressed for an effective fight against tobacco induced disease.
- Review the organs affected by tobacco and the many ways in which tobacco-related injury causes impairment and death
- Explain the biologic predisposition for smoking addiction.
- Develop strategies to offer more effective smoking cessation counseling
- Develop strategies to increase use of “preventive” recommendations for younger adults
- Better educate patients about their diseases and their cause.
- Describe ways in which our understanding of lung cancer has change
- Compare and contrast utilizing a multi-disciplinary approach to lung cancer.
AMA Designation Statement: “The UAMS College of Medicine designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
ADA statement: UAMS is committed to providing reasonable accommodations to individuals with disabilities. If you need an accommodation due to a disability, please contact Kasheena Green at 501-526-2272 ext. 8014 by Tuesday, Nov. 5th.
The Arkansas State Board of Pharmacy is pleased to approve the Continuing Education (CE) program for 7.50 credit hours.
The Respiratory Care Examining Committee of the Arkansas State Medical Board is pleased to approve the Continuing Education (CE) program for 7.50 credit hours for respiratory therapists.
This activity has been submitted to Arkansas Nurses Association for approval to award 7.50 contact hours. Arkansas Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
The University of Arkansas for Medical Sciences (UAMS) College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
It is the policy of the University of Arkansas for Medical Sciences (UAMS) College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all sponsored or jointly sponsored educational activities. All individuals who are in a position to control the content of the educational activity (course/activity directors, planning committee members, staff, teachers, or authors of CME) must disclose all relevant financial relationships they have with any commercial interest(s) as well as the nature of the relationship. Financial relationships of the individual’s spouse or partner must also be disclosed, if the nature of the relationship could influence the objectivity of the individual in a position to control the content of the CME. The ACCME describes relevant financial relationships as those in any amount occurring within the past 12 months that create a conflict of interest. Individuals who refuse to disclose will be disqualified from participation in the development, management, presentation, or evaluation of the CME activity.